HLA-G
HLA class I histocompatibility antigen, alpha chain G
Also known as: HLAG_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P17693
- Gene
- HLA-G
- Ensembl
- ENSG00000204632
- Chromosome
- 6
- Canonical length
- 338 aa
- Protein class
- Cancer-related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins
- Secretome location
- Secreted to blood
- Quaternary structure
- Homotrimer
OverviewNCBI Gene
HLA-G belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. HLA-G is expressed on fetal derived placental cells. The heavy chain is approximately 45 kDa and its gene contains 8 exons. Exon one encodes the leader peptide, exons 2 and 3 encode the alpha1 and alpha2 domain, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region, and exon 6 encodes the cytoplasmic tail. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
338 residues, UniProt reviewed canonical sequence.
>P17693|HLA-G
1 MVVMAPRTLF LLLSGALTLT ETWAGSHSMR YFSAAVSRPG RGEPRFIAMG YVDDTQFVRF
61 DSDSACPRME PRAPWVEQEG PEYWEEETRN TKAHAQTDRM NLQTLRGYYN QSEASSHTLQ
121 WMIGCDLGSD GRLLRGYEQY AYDGKDYLAL NEDLRSWTAA DTAAQISKRK CEAANVAEQR
181 RAYLEGTCVE WLHRYLENGK EMLQRADPPK THVTHHPVFD YEATLRCWAL GFYPAEIILT
241 WQRDGEDQTQ DVELVETRPA GDGTFQKWAA VVVPSGEEQR YTCHVQHEGL PEPLMLRWKQ
301 SSLPTIPIMG IVAGLVVLAA VVTGAAVAAV LWRKKSSDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against HLA-G can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 14 nTPM
Expression across tissuesHPA
Tissue
- pituitary gland: 14 nTPM
- placenta: 11 nTPM
- lung: 2.7 nTPM
- testis: 2.5 nTPM
- pancreas: 1.1 nTPM
- spleen: 1 nTPM
Single-cell type
- extravillous trophoblasts: 714 nCPM
- alveolar cells type 1: 29 nCPM
- migrating cytotrophoblasts: 26 nCPM
- platelets: 23 nCPM
- early spermatids: 21 nCPM
- late spermatids: 11 nCPM
Immune cell
- total PBMC: 2.5 nTPM
- MAIT T-cell: 0.8 nTPM
- memory CD8 T-cell: 0.7 nTPM
- naive CD8 T-cell: 0.7 nTPM
- neutrophil: 0.7 nTPM
- eosinophil: 0.6 nTPM
Brain region
- amygdala: 0 nTPM
- basal ganglia: 0 nTPM
- cerebellum: 0 nTPM
- cerebral cortex: 0 nTPM
- choroid plexus: 0 nTPM
- hippocampal formation: 0 nTPM
ReferencesPubMed · IEDB
Publications for HLA-G from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
2 publications
- Serum antibodies to human leucocyte antigen (HLA)-E, HLA-F and HLA-G in patients with systemic lupus erythematosus (SLE) during disease flares: Clinical relevance of HLA-F autoantibodies.
2016 · Clin Exp Immunol · RCR 0.8 · 20 citations - Low Prevalence of HLA-G Antibodies in Lung Transplant Patients Detected using MAIPA-Adapted Protocol.
2023 · Int J Mol Sci · RCR 0.6 · 2 citations
Reference: T cellIEDB
6 publications
- Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells.
1999 · J Exp Med · RCR 3.6 · 189 citations - Structural basis for a major histocompatibility complex class Ib-restricted T cell response.
2006 · Nat Immunol · RCR 1.9 · 102 citations - Human T cell receptor-mediated recognition of HLA-E.
2002 · Eur J Immunol · RCR 1.5 · 90 citations - HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes.
2004 · Hum Immunol · RCR 0.8 · 47 citations - The Presence of HLA-E-Restricted, CMV-Specific CD8+ T Cells in the Blood of Lung Transplant Recipients Correlates with Chronic Allograft Rejection.
2015 · PLoS One · RCR 0.7 · 23 citations
Show 1 more
- Human Cytomegalovirus Antigen Presentation by HLA-G in Infected Cells.
2025 · HLA · 1 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.46
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.23
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
OntologyGO
Biological processes
- antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent
- antigen processing and presentation of endogenous peptide antigen via MHC class Ib
- cellular defense response
- immune response
- immune response-inhibiting cell surface receptor signaling pathway
- negative regulation of angiogenesis
- negative regulation of dendritic cell differentiation
- negative regulation of G0 to G1 transition
- negative regulation of immune response
- negative regulation of natural killer cell mediated cytotoxicity
- negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- negative regulation of T cell mediated cytotoxicity
- negative regulation of T cell proliferation
- positive regulation of cellular senescence
- positive regulation of endothelial cell apoptotic process
- positive regulation of interleukin-12 production
- positive regulation of macrophage cytokine production
- positive regulation of natural killer cell cytokine production
- positive regulation of regulatory T cell differentiation
- positive regulation of T cell mediated cytotoxicity
- positive regulation of T cell tolerance induction
- positive regulation of tolerance induction
- protection from natural killer cell mediated cytotoxicity
- protein homotrimerization
- peripheral B cell tolerance induction
Molecular functions
- CD8 receptor binding
- identical protein binding
- peptide antigen binding
- protein homodimerization activity
- signaling receptor binding
Cellular components
- cis-Golgi network membrane
- early endosome
- early endosome membrane
- ER to Golgi transport vesicle membrane
- external side of plasma membrane
- extracellular space
- filopodium membrane
- Golgi membrane
- lumenal side of endoplasmic reticulum membrane
- membrane
- MHC class I protein complex
- phagocytic vesicle membrane
- plasma membrane
- recycling endosome membrane
Protein domainsUniProt · Pfam · InterPro
- MHC class I alpha chain, alpha1 alpha2 domains
- Immunoglobulin/major histocompatibility complex, conserved site
- Immunoglobulin C1-set
- Immunoglobulin-like domain
- MHC class I-like antigen recognition-like
- MHC classes I/II-like antigen recognition protein
- Immunoglobulin-like fold
- Immunoglobulin-like domain superfamily
- MHC class I-like antigen recognition-like superfamily
- Antigen-presenting and immune regulatory MHC class I-related
- Class I Histocompatibility antigen, domains alpha 1 and 2
- Immunoglobulin C1-set domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of HLA-G in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HLA-G as an antibody target. Whether an autoantibody or antibody against HLA-G could matter depends on whether native HLA-G is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HLA-G is annotated at the cell surface, where native HLA-G is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label HLA-G as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...